• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Centivax, Inc.

Monday, June 03, 2024
CP
Infectious Disease and Vaccines
Centivax is a broad-spectrum vaccine platform technology company. Founded by leading experts in pharmaceutical development, immunology, vaccine science, computational biology, and broadly neutralizing antibody engineering, Centivax is on a mission to accelerate the world’s transition to a post-pathogen humanity. Centivax has developed an epitope-focusing vaccine platform for use in developing broad-spectrum vaccines for rapidly mutating pathogens. This patented broad-spectrum vaccine platform has demonstrated unprecedented breadth of protection from influenza in ferrets and pigs. Centivax platform development has been backed by the Bill and Melinda Gates Foundation, the National Institute of Health (NIH), the Naval Medical Research Center, the Walter Reed Army Institute of Research, the Medical Technology Enterprise Consortium, the Department of Defense, the National Institute for Innovation in Manufacturing Biopharmaceuticals, NFX, and the Global Health Investment Corporation.
Centivax, Inc.
Company Website: http://www.centivax.com
Lead Product in Development: broad spectrum influenza vaccine
Number Of Unlicensed Products (For Which You Are Seeking Partners): 6

Website

http://www.centivax.com

Company HQ City

South San Francisco

Company HQ State

California

Company HQ Country

United States

CEO/Top Company Official

YES

Lead Product in Development

broad spectrum influenza vaccine

Development Phase of Primary Product

Pre-Clinical
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS